Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...

Rare Disease Genetic Testing Market to Reach USD 3.79 Billion by 2032 | Growth is Driven by Rising Demand for Early Diagnostic Solutions Globally – SNS Insider

Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...

DNAe Unveils Early Access Program for LiDia‑SEQ™: Hospital Teams Invited to Trial DNAe's Flagship Tests and Preview DNAe's Innovative NGS Diagnostic Platform

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...

Delhi airport to use next-gen AI and enhanced runways to tackle winter chaos

AI-Powered systems and runway upgrades aim to significantly reduce flight disruptions from fog at Delhi's IGI airport.
FMIBlog

Molecular Biology Enzymes, Kits & Reagents Market Set for Strong Growth with 9.5% CAGR Through 2035

The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...